Shanghai Shyndec Pharmaceutical Co., Ltd.
SHH: 600420.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yong Liu
- Employees
- 11,472
- Headquarters
- Shanghai, China
- IPO year
- 2004
- Market cap
- CN¥12.9B
- Website
- https://www.shyndec.com
Loading 600420…
Loading profile data…Frequently asked questions about 600420
What does Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) do?
Shanghai Shyndec Pharmaceutical Co., Ltd. manufactures drug preparation products in China and internationally. It focuses on anti-infection, cardiovascular and cerebrovascular, anti-tumor, metabolism, and endocrine areas. The company was founded in 1996 and is based in Shanghai, China.
Where does 600420.SS trade?
Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) trades on the Shanghai Stock Exchange.
What sector is 600420.SS in?
Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shanghai Shyndec Pharmaceutical Co., Ltd.?
Yong Liu is the chief executive officer of Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS).
Where is Shanghai Shyndec Pharmaceutical Co., Ltd. headquartered?
Shanghai Shyndec Pharmaceutical Co., Ltd. is headquartered in China.
Does 600420.SS pay a dividend?
Yes — Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600420.SS go public?
Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS) completed its initial public offering in 2004.